A novel approach to facilitate dopaminergic neuron generation from stem-cells: The combination of genetic modification and signaling factors within a three-dimensional perfusion microbioreactor

Medical Hypotheses

Volumn 80, Issue 4, 2013, Pages 407-410

  Song, Lin ^a,b   Liu, Peng ^a   Han, Chao ^a   Liu, Yang ^a   Zou, Wei ^c   Piao, Hua ^a   Wang, Yachen ^a   Liu, Jing ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b DALIAN UNIVERSITY OF TECHNOLOGY   (China)

^c LIAONING NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LMX1 PROTEIN; NUCLEAR RECEPTOR RELATED FACTOR 1; PROTEIN; TRANSCRIPTION FACTOR MASH1; TRANSCRIPTION FACTOR PITX3; UNCLASSIFIED DRUG;

ARTICLE; BIOREACTOR; COCULTURE; DNA MODIFICATION; DOPAMINERGIC NERVE CELL; HUMAN; HUMAN CELL; NERVE CELL DIFFERENTIATION; NERVE CELL NETWORK; NERVE GROWTH; STEM CELL; THREE DIMENSIONAL PERFUSION MICROBIOREACTOR;

ANIMALS; BATCH CELL CULTURE TECHNIQUES; BIOREACTORS; CELL DIFFERENTIATION; CELLS, CULTURED; DOPAMINERGIC NEURONS; EQUIPMENT DESIGN; GENETIC ENHANCEMENT; HUMANS; PERFUSION; STEM CELLS;

EID: 84875400464     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2012.12.029     Document Type: Article

References (44)

1. Marsden C.D. Parkinson's disease. J Neurol Neurosurg Psychiatry 1994, 57(6):672-681.
2. Arias-Carrion O., Hernandez-Lopez S., Ibanez-Sandoval O., Bargas J., Hernandez-Cruz A., Drucker-Colin R. Neuronal precursors within the adult rat subventricular zone differentiate into dopaminergic neurons after substantia nigra lesion and chromafin cell transplant. J Neurosci Res 2006, 84:1425-1437.
3. Tønnesen J., Parish C.L., Sørensen A.T., et al. Functional integration of grafted neural stem cell-derived dopaminergic neurons monitored by optogenetics in an in vitro Parkinson model. PLoS One 2011, 6(3):e17560.
4. Watmuff B., Pouton C.W., Haynes J.M. In vitro maturation of dopaminergic neurons derived from mouse embryonic stem cells: implications for transplantation. PLoS One 2012, 7(2):e31999.
5. Ganat Y.M., Calder E.L., Kriks S., et al. Identification of embryonic stem cell-derived midbrain dopaminergic neurons for engraftment. J Clin Invest 2012, 122(8):2928-2939.
6. Daadi M.M., Grueter B.A., Malenka R.C., et al. Dopaminergic neurons from midbrain-specified human embryonic stem cell-derived neural stem cells engrafted in a monkey model of Parkinson's disease. PLoS One 2012, 7(7):e41120.
7. Venkataramana N.K., Pal R., Rao S.A.V., et al. Bilateral transplantation of allogenic adult human bone marrow-derived mesenchymal stem cells into the subventricular zone of Parkinson's disease: a pilot clinical study. Stem Cells Int 2012, 1-12. Article ID 931902.
8. Lindvall O., Kokaia Z. Stem cells for the treatment of neurological disorders. Nature 2006, 441(7097):1094-1096.
9. Vidaltamayo R., Bargas J., Covarrubias L., et al. Stem cell therapy for Parkinson's disease: a roadmap for a successful future. Stem Cells Dev 2010, 19(3):311-319.
10. Caiazzo M., Dell'Anno M.T., Dvoretskova E., et al. Direct generation of functional dopaminergic neurons from mouse and human fibroblasts. Nature 2011, 476(7359):224-227.
11. Pfisterer U., Kirkeby A., Torper O., et al. Direct conversion of human fibroblasts to dopaminergic neurons. Proc Natl Acad Sci 2011, 108(25):10343-10348.
12. Liu X., Li F., Stubblefield E.A., et al. Direct reprogramming of human fibroblasts into dopaminergic neuron-like cells. Cell Res 2012, 22(2):321-332.
13. Vazin T., Becker K.G., Chen J., et al. A novel combination of factors, termed SPIE, which promotes dopaminergic neuron differentiation from human embryonic stem cells. PLoS One 2009, 4(8):e6606.
14. Trzaska K.A., King C.C., Li K.Y., et al. Brain-derived neurotrophic factor facilitates maturation of mesenchymal stem cell-derived dopamine progenitors to functional neurons. J. Neurochem 2009, 110:1058-1069.
15. Wang F.F., Yasuhara T., Shingo T., et al. Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: focusing on neuroprotective effects of stromal cell-derived factor-1α. BMC Neurosci 2010, 11:52.
16. Lai Y., Drobinskaya I., Kolossov E., Chen C.G., Linn T. Genetic modification of cells for transplantation. Adv Drug Deliv Rev 2008, 60:146-159.
17. Schambach A., Cantz T., Baum C., Cathomen T. Generation and genetic modification of induced pluripotent stem cells. Expert Opin Biol Ther 2010, 10(7):1089-1103.
18. Nieminen M., Tuuri T., Savilahti H. Genetic recombination pathways and their application for genome modification of human embryonic stem cells. Exp Cell Res 2010, 316:2578-2586.
19. Yan C.H., Levesque M., Claxton S., Johnson R.L., Ang S.L. Lmx1a and lmx1b function cooperatively to regulate proliferation, specification, and differentiation of midbrain dopaminergic progenitors. J Neurosci 2011, 31(35):12413-12425.
20. Friling S., Andersson E., Thompson L.H., et al. Efficient production of mesencephalic dopamine neurons by Lmx1a expression in embryonic stem cells. PNAS 2009, 106(18):7613-7618.
21. Andersson E., Tryggvason U., Deng Q.L., et al. Identification of intrinsic determinants of midbrain dopamine neurons. Cell 2006, 124:393-405.
22. Cai J.L., Donaldson A., Yang M., et al. The role of Lmx1a in the differentiation of human embryonic stem cells into midbrain dopamine neurons in culture and after transplantation into a Parkinson's disease model. Stem Cells 2009, 27:220-229.
23. Barzilay R., Ben-Zur T., Bulvik S., Melamed E., Offen D. Lentiviral delivery of LMX1a enhances dopaminergic phenotype in differentiated human bone marrow mesenchymal stem cells. Stem Cells Dev 2009, 18(4):591-601.
24. Kim T.E., Lee H.S., Lee Y.B., et al. Sonic hedgehog and FGF8 collaborate to induce dopaminergic phenotypes in the Nurr1-overexpressing neural stem cell. Biochem Biophys Res Commun 2003, 305(4):1040-1048.
25. Peng C., Aron L., Klein R., et al. Pitx3 is a critical mediator of GDNF-induced BDNF expression in nigrostriatal dopaminergic neurons. J Neurosci 2011, 31(36):12802-12815.
26. Kele J., Simplicio N., et al. Neurogenin 2 is required for the development of ventral midbrain dopaminergic neurons. Development 2006, 133(3):495-505.
27. Roybon L., Hjalt T., Christophersen N.S., Li J.Y., Brundin P. Effects on differentiation of embryonic ventral midbrain progenitors by Lmx1a, Msx1, Ngn2, and Pitx3. J Neurosci 2008, 28(14):3644-3656.
28. Pfisterer U., Kirkeby A., Torper O., et al. Direct conversion of human fibroblasts to dopaminergic neurons. PNAS 2011, 108(25):10343-10348.
29. Pang Z.P., Yang N., Vierbuchen T., et al. Induction of human neuronal cells by defined transcription factors. Nature 2011, 476(7359):220-223.
30. Yu Y., Gu S., Huang H., Wen T. Combination of bFGF, heparin and laminin induce the generation of dopaminergic neurons from rat neural stem cells both in vitro and in vivo. J Neurol Sci 2007, 255(1-2):81-86.
31. Trzaska K.A., King C.C., Li K.Y., et al. Brain-derived neurotrophic factor facilitates maturation of mesenchymal stem cell-derived dopamine progenitors to functional neurons. J Neurochem 2009, 110(3):1058-1069.
32. Gu S., Huang H., Bi J., Yao Y., Wen T. Combined treatment of neurotrophin-3 gene and neural stem cells is ameliorative to behavior recovery of Parkinson's disease rat model. Brain Res 2009, 1257:1-9.
33. Lei Z., Jiang Y., Li T., Zhu J., Zeng S. Signaling of glial cell line-derived neurotrophic factor and its receptor GFRα1 induce Nurr1 and Pitx3 to promote survival of grafted midbrain-derived neural stem cells in a rat model of Parkinson disease. J Neuropathol Exp Neurol 2011, 70(9):736-747.
34. Trzaska K.A., Rameshwar P. Dopaminergic neuronal differentiation protocol for human mesenchymal stem cells. Methods Mol Biol 2011, 698:295-303.
35. Liu J., He Q.J., Zou W., Wang H.X., Bao Y.M., Liu Y.X., et al. Catalpol increases hippocampal neuroplasticity and up-regulates PKC and BDNF in the aged rats. Brain Res 2006, 1123(1):68-79.
36. Lee J.H., Yu H.S., Lee G.S., et al. Collagen gel three-dimensional matrices combined with adhesive proteins stimulate neuronal differentiation of mesenchymal stem cells. J R Soc Interface 2011, 8:998-1010.
37. Cui Z.F., Xu X., Trainor N., Triffitt J.T., Urban J.P., Tirlapur U.K. Application of multiple parallel perfused microbioreactors and three-dimensional stem cell culture for toxicity testing. Toxicology In Vitro 2007, 21(7):1318-1324.
38. Wu M.H., Urban J.P.G., Cui Z., Cui Z.F. Development of PDMS microbioreactor with well-defined and homogenous culture environment for chondrocyte 3-D culture. Biomed Microdevices 2006, 8:331-340.
39. Li N., Feugier P., Serrurrier B., et al. Human mesenchymal stem cells improve ex vivo expansion of adult human CD34 (+) peripheral blood progenitor cells and decrease their allostimulatory capacity. Exp Hematol 2007, 35(3):507-515.
40. Boehler M.D., Wheeler B.C., Brewer G.J. Added astroglia promote greater synapse density and higher activity in neuronal networks. Neuron Glia Biol 2007, 3:127-140.
41. Willerth S.M., Arendas K.J., Gottlieb D.I., Sakiyama-Elbert S.E. Optimization of fibrin scaffolds for differentiation of murine embryonic stem cells into neural lineage cells. Biomaterials 2006, 27(36):5990-6003.
42. Mazzatenta A., Giugliano M., Campidelli S., et al. Interfacing neurons with carbon nanotubes: electrical signal transfer and synaptic stimulation in cultured brain circuits. J Neurosci 2007, 27(26):6931-6936.
43. He J., Wang X.M., Spector M., Cui F.Z. Scaffolds for central nervous system tissue engineering. Front Mater Sci 2012, 6(1):1-25.
44. Han C, Song L, Liu Y, et al. Human adipose-derived mesenchymal stem cells: a better cell source for nervous system diseases application. Chinese Medical Journal in press.